相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Variation in Mutant Prevention Concentrations
Crystal Gianyecchio et al.
FRONTIERS IN MICROBIOLOGY (2019)
Chemotherapeutic control of Gram-positive infection in white sea bream (Diplodus sargus, Linnaeus 1758) broodstock
Nadia G. M. Ali et al.
VETERINARY WORLD (2019)
Recurrent Streptoccoccus agalactiae infection in Nile tilapia (Oreochromis niloticus) treated with florfenicol
Thais Ferreira de Oliveira et al.
AQUACULTURE (2018)
Comparative pharmacokinetics of oxytetracycline in tilapia (Oreochromis spp.) maintained at three different salinities
Pritam K. Sidhu et al.
AQUACULTURE (2018)
Molecular serotyping, virulence gene profiling and pathogenicity of Streptococcus agalactiae isolated from tilapia farms in Thailand by multiplex PCR
K. Kannika et al.
JOURNAL OF APPLIED MICROBIOLOGY (2017)
Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida
L. Dorey et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2017)
PK-PD Analysis of Marbofloxacin against Streptococcus suis in Pigs
Zhixin Lei et al.
FRONTIERS IN PHARMACOLOGY (2017)
Emergence of a new multidrug-resistant and highly virulent serotype of Streptococcus agalactiae in fish farms from Brazil
Roberta T. Chideroli et al.
AQUACULTURE (2017)
Antimicrobial susceptibility and enrofloxacin resistance of streptococcal bacteria from farmed Nile tilapia, Oreochromis niloticus (Linnaeus 1758) in Thailand
Mintra Lukkana et al.
AQUACULTURE RESEARCH (2016)
Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats
Emilio Fernandez-Varon et al.
BMC VETERINARY RESEARCH (2016)
Serotype distribution and antimicrobial susceptibilities of Streptococcus agalactiae isolated from infected cultured tilapia (Oreochromis niloticus) in Thailand: Nine-year perspective
Machalin Dangwetngam et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2016)
A critical approach on pharmacokinetics, pharmacodynamics, dose optimisation and withdrawal times of oxytetracycline in aquaculture
George Rigos et al.
REVIEWS IN AQUACULTURE (2015)
Comprehensive Investigation of Streptococcosis Outbreaks in Cultured Nile Tilapia, Oreochromis niloticus, and Red Tilapia, Oreochromis sp., of Thailand
Sasibha Jantrakajorn et al.
JOURNAL OF THE WORLD AQUACULTURE SOCIETY (2014)
Pharmacokinetic-pharmacodynamic (PK-PD) modeling and the rational selection of dosage regimes for the prudent use of antimicrobial drugs
Mark G. Papich
VETERINARY MICROBIOLOGY (2014)
Integrated pharmacokinetics/pharmacodynamics parameters-based dosing guidelines of enrofloxacin in grass carp Ctenopharyngodon idella to minimize selection of drug resistance
Lijuan Xu et al.
BMC VETERINARY RESEARCH (2013)
Mutant prevention concentration and PK-PD relationships of enrofloxacin for Pasteurella multocida in buffalo calves
R. M. Balaje et al.
RESEARCH IN VETERINARY SCIENCE (2013)
Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi
Londa J. Berghaus et al.
VETERINARY MICROBIOLOGY (2013)
Oxytetracycline Pharmacokinetics in Rainbow Trout during and after an Orally Administered Medicated Feed Regimen
Ron A. Miller et al.
JOURNAL OF AQUATIC ANIMAL HEALTH (2012)
Comparative mutant prevention concentration and mechanism of resistance to veterinary fluoroquinolones in Staphylococcus pseudintermedius
Elias Gebru Awji et al.
VETERINARY DERMATOLOGY (2012)
Mutant Prevention Concentration-Based Pharmacokinetic/Pharmacodynamic Indices as Dosing Targets for Suppressing the Enrichment of Levofloxacin-Resistant Subpopulations of Staphylococcus aureus
Beibei Liang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Streptococcus agalactiae the Etiological Agent of Mass Mortality in Farmed Red Tilapia (Oreochromis sp.)
Ali Abuseliana et al.
Journal of Animal and Veterinary Advances (2010)
Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii
Jun-Chang Cui et al.
JOURNAL OF ANTIBIOTICS (2010)
New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach
Joseph M. Blondeau
VETERINARY DERMATOLOGY (2009)
In Vitro Activity of Tigecycline: MICs, MBCs, Time-Kill Curves and Post-Antibiotic Effect
S. Noviello et al.
JOURNAL OF CHEMOTHERAPY (2008)
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
Irith Wiegand et al.
NATURE PROTOCOLS (2008)
Pharmacokinetics and residue elimination of oxytetracycline in grass carp, Ctenopharyngodon idellus
Qizhong Zhang et al.
AQUACULTURE (2007)
In vitro antibacterial activities of tigecycline and comparative agents by time-kill kinetic studies in fresh Mueller-Hinton broth
Peter J. Petersen et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Mutant selection window hypothesis updated
Karl Drlica et al.
CLINICAL INFECTIOUS DISEASES (2007)
Pharmacokinetics-pharmacodynamics of antimicrobial therapy: It's not just for mice anymore
Paul G. Ambrose et al.
CLINICAL INFECTIOUS DISEASES (2007)
Low correlation between MIC and mutant prevention concentration
K Drlica et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Bioavailability of oxytetracycline in sea bass, Dicentrarchus labrax (L.)
G Rigos et al.
JOURNAL OF FISH DISEASES (2004)
The changing face of antibiotic prescribing: The mutant selection window
BJ Epstein et al.
ANNALS OF PHARMACOTHERAPY (2004)
Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine
PL Toutain et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2004)
Oxytetracycline residues in four species of fish after 10-day oral dosing in feed
CY Chen et al.
JOURNAL OF AQUATIC ANIMAL HEALTH (2004)
Evolution of ciprofloxacin-resistant Staphylococcus aureus in in vitro pharmacokinetic environments
JJ Campion et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Basic pharmacodynamics of antibacterials with clinical applications to the use of β-lactams, glycopeptides, and linezolid
WA Craig
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2003)
In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteria
ML van Ogtrop et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
